[HTML][HTML] Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a …

…, PS Freemont, GP Taylor, S Ahmad… - The lancet infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading
globally, including in populations with high vaccination rates. We aimed to investigate …

[HTML][HTML] Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

…, B Hallis, L Stapley, R Borrow, E Linley, S Ahmad… - Nature …, 2021 - nature.com
The immune response to SARS-CoV-2 is critical in controlling disease, but there is concern
that waning immunity may predispose to reinfection. We analyzed the magnitude and …

[HTML][HTML] Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection

…, F Baawuah, J Beckmann, IO Okike, S Ahmad… - Nature …, 2022 - nature.com
SARS-CoV-2 infection is generally mild or asymptomatic in children but a biological basis
for this outcome is unclear. Here we compare antibody and cellular immunity in children (aged …

[HTML][HTML] Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study

…, R Kundu, MA Crone, TD Pillay, S Ahmad… - The Lancet …, 2022 - thelancet.com
Background Knowledge of the window of SARS-CoV-2 infectiousness is crucial in
developing policies to curb transmission. Mathematical modelling based on scarce empirical …

[HTML][HTML] Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning

B Vekaria, C Overton, A Wiśniowski, S Ahmad… - BMC Infectious …, 2021 - Springer
Background Predicting hospital length of stay (LoS) for patients with COVID-19 infection is
essential to ensure that adequate bed capacity can be provided without unnecessarily …

[HTML][HTML] Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey

AG Mathioudakis, M Ghrew, A Ustianowski, S Ahmad… - Life, 2021 - mdpi.com
An online survey was conducted to compare the safety, tolerability and reactogenicity of
available COVID-19 vaccines in different recipient groups. This survey was launched in …

[HTML][HTML] Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo …

…, G Saunders, C Middleton, S Ahmad… - The Lancet Infectious …, 2023 - thelancet.com
Background The antiviral drug molnupiravir was licensed for treating at-risk patients with
COVID-19 on the basis of data from unvaccinated adults. We aimed to evaluate the safety and …

[HTML][HTML] SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study

…, J Beckmann, IO Okike, S Ahmad… - The Lancet Child & …, 2021 - thelancet.com
Background Little is known about the risk of SARS-CoV-2 infection and transmission in
educational settings. Public Health England initiated a study, COVID-19 Surveillance in School …

Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study

…, S Foster, J Evans, MD Lyttle, S Ahmad… - Archives of disease in …, 2021 - adc.bmj.com
Background Studies based on molecular testing of oral/nasal swabs underestimate SARS-CoV-2
infection due to issues with test sensitivity, test timing and selection bias. The objective …

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers

…, J Flood, R Borrow, E Linley, S Ahmad… - Journal of Infection, 2021 - Elsevier
Background Antibody waning after SARS-CoV-2 infection may result in reduction in long-term
immunity following natural infection and vaccination, and is therefore a major public health …